Asia Pacific Aesthetic Injectable Devices Market Size and Forecast (2021

List of Tables

The Asia Pacific aesthetic injectable devices market is projected to grow from US$ 1,290.9 million in 2024 to US$ 2,253.9 million by 2031, registering a CAGR of 8.5% during 2025-2031.

Executive Summary & Market Overview:

The market across Asia Pacific-including China, Japan, India, South Korea, and Australia-is expanding rapidly due to rising disposable incomes and increasing urbanization. Consumers are spending more on cosmetic enhancements, particularly non-invasive procedures such as Botox and dermal fillers. Growing awareness of beauty, youthfulness, and self-care-fueled by social media and global beauty standards-is further accelerating demand.

Demographic trends also play a key role. Aging populations in countries like Japan, South Korea, and China are driving demand for anti-aging treatments, while younger consumers are increasingly adopting injectables as preventive measures. The region's thriving medical tourism industry, offering high-quality treatments at competitive prices, is another significant growth factor. Technological advancements, improved access to trained professionals, and greater digital awareness are making aesthetic procedures more accessible and trusted.

Segmentation Insights:

By product, botulinum toxin dominated the market in 2024, followed by dermal fillers.

Among dermal fillers, hyaluronic acid held the largest share.

By device, pre-filled syringes led the segment.

By application, facial line correction accounted for the largest share.

By age group, individuals aged 31-40 represented the dominant segment.

By gender, females held the majority share.

By end user, dermatology clinics led the market.

Market Outlook:

The rising global aging population is a major driver of demand for aesthetic injectables. As collagen and elastin levels decline with age, individuals increasingly seek minimally invasive solutions to address wrinkles, volume loss, and skin laxity. Treatments such as botulinum toxin injections and hyaluronic acid fillers provide effective results with minimal downtime, aligning with modern preferences.

At the same time, younger demographics are contributing to market growth through the trend of "preventative Botox," using injectables early to delay visible aging signs. Social media and celebrity culture continue to shape beauty standards, increasing the desire for flawless and youthful appearances across age groups. This combination of aging-related needs and preventive care is broadening the market base significantly.

Country Insights:

China led the regional market in 2024, driven by rising awareness of aesthetic treatments and strong demand for noninvasive procedures. Unlike Western markets that focus heavily on anti-aging, China sees substantial demand from younger consumers influenced by social media and digital content platforms.

Technological innovation is also strengthening the market. Advanced dermal fillers with improved longevity and comfort are enhancing patient outcomes. Several product launches and regulatory approvals-ranging from hyaluronic acid fillers to regenerative biostimulators-highlight the country's growing role as a hub for aesthetic innovation. Companies are also expanding treatment applications and introducing new formulations to meet evolving consumer expectations.

Key Market Players:

Major companies operating in the region include Merz Pharma GmbH & Co. KGaA, AbbVie Inc., Ipsen SA, Galderma SA, Revance Therapeutics Inc., Evolus Inc., and Hugel Inc., among others. These players are focusing on product innovation, partnerships, and expansion strategies to strengthen their market presence.

Product Code: TIPRE00041911

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

4. Aesthetic Injectable Devices Market Landscape

4.2 PEST Analysis
4.3 Global and Regional Average Cost Range, 2024

4. Asia Pacific Aesthetic Injectable Devices Market - Key Market Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:

5. Aesthetic Injectable Devices Market - Asia Pacific Market Analysis

5.1 Asia Pacific Aesthetic Injectable Devices Market Revenue (US$ Million), 2024 - 2031
5.2 Asia Pacific Aesthetic Injectable Devices Market Forecast and Analysis

6. Asia Pacific Aesthetic Injectable Devices Market Revenue Analysis - by Product

6.1 Dermal Filler
- 6.1.1 Overview
- 6.1.2 Dermal Filler: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Botulinum Toxin
- 6.2.1 Overview
- 6.2.2 Botulinum Toxin: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Others
- 6.3.1 Overview
- 6.3.2 Others: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

7. Asia Pacific Aesthetic Injectable Devices Market Revenue Analysis - by Dermal Fillers

7.1 Calcium Hydroxylapatite
- 7.1.1 Overview
- 7.1.2 Calcium Hydroxylapatite: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Hyaluronic Acid
- 7.2.1 Overview
- 7.2.2 Hyaluronic Acid: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Collagen
- 7.3.1 Overview
- 7.3.2 Collagen: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Poly-L-Lactic Acid
- 7.4.1 Overview
- 7.4.2 Poly-L-Lactic Acid: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Polymethylmethacrylate (PMMA)
- 7.5.1 Overview
- 7.5.2 Polymethylmethacrylate (PMMA): Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Fat Fillers
- 7.6.1 Overview
- 7.6.2 Fat Fillers: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

10. Asia Pacific Aesthetic Injectable Devices Market Revenue Analysis - by Device

10.1 Microcannulas
- 10.1.1 Overview
- 10.1.2 Microcannulas: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Pre-Filled Syringes
- 10.2.1 Overview
- 10.2.2 Pre-Filled Syringes: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Mesotherapy Guns
- 10.3.1 Overview
- 10.3.2 Mesotherapy Guns: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Others
- 10.4.1 Overview
- 10.4.2 Others: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9. Asia Pacific Aesthetic Injectable Devices Market Revenue Analysis - by Application

9.1 Facial Line Correction
- 9.1.1 Overview
- 9.1.2 Facial Line Correction: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Face Lift
- 9.2.1 Overview
- 9.2.2 Face Lift: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Lip Treatment
- 9.3.1 Overview
- 9.3.2 Lip Treatment: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Anti-Ageing and Wrinkle Treatment
- 9.4.1 Overview
- 9.4.2 Anti-Ageing and Wrinkle Treatment: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Acne and Scar Treatment
- 9.5.1 Overview
- 9.5.2 Acne and Scar Treatment: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Stretch Marks
- 9.6.1 Overview
- 9.6.2 Stretch Marks: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

10. Asia Pacific Aesthetic Injectable Devices Market Revenue Analysis - by Age Group

10.1 Up to 30
- 10.1.1 Overview
- 10.1.2 Up to 30: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 31-40
- 10.2.1 Overview
- 10.2.2 31-40: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 41-50
- 10.3.1 Overview
- 10.3.2 41-50: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 51-60
- 10.4.1 Overview
- 10.4.2 51-60: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 More Than 60
- 10.5.1 Overview
- 10.5.2 More Than 60: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

11. Asia Pacific Aesthetic Injectable Devices Market Revenue Analysis - by Gender

11.1 Female
- 11.1.1 Overview
- 11.1.2 Female: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Male
- 11.2.1 Overview
- 11.2.2 Male: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

12. Asia Pacific Aesthetic Injectable Devices Market Revenue Analysis - by End User

12.1 Medical Spas
- 12.1.1 Overview
- 12.1.2 Medical Spas: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Dermatology Clinics
- 12.2.1 Overview
- 12.2.2 Dermatology Clinics: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Hospitals
- 12.3.1 Overview
- 12.3.2 Hospitals: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.4 Others
- 12.4.1 Overview
- 12.4.2 Others: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

13. Asia Pacific Aesthetic Injectable Devices Market - Country Analysis

13.1 Asia Pacific
- 13.1.1 Asia Pacific Aesthetic Injectable Devices Market Revenue and Forecast and Analysis - by Country
  - 13.1.1.1 Asia Pacific Aesthetic Injectable Devices Market Revenue and Forecast and Analysis - by Country
  - 13.1.2.2 China: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.1.2.2.1 China: Asia Pacific Aesthetic Injectable Devices Market Share - by Product
    - 13.1.2.2.2 China: Asia Pacific Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 13.1.2.2.3 China: Asia Pacific Aesthetic Injectable Devices Market Share - by Device
    - 13.1.2.2.4 China: Asia Pacific Aesthetic Injectable Devices Market Share - by Application
    - 13.1.2.2.5 China: Asia Pacific Aesthetic Injectable Devices Market Share - by Age Group
    - 13.1.2.2.6 China: Asia Pacific Aesthetic Injectable Devices Market Share - by Gender
    - 13.1.2.2.7 China: Asia Pacific Aesthetic Injectable Devices Market Share - by End User
  - 13.2.3.3 Japan: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.2.3.3.1 Japan: Asia Pacific Aesthetic Injectable Devices Market Share - by Product
    - 13.2.3.3.2 Japan: Asia Pacific Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 13.2.3.3.3 Japan: Asia Pacific Aesthetic Injectable Devices Market Share - by Device
    - 13.2.3.3.4 Japan: Asia Pacific Aesthetic Injectable Devices Market Share - by Application
    - 13.2.3.3.5 Japan: Asia Pacific Aesthetic Injectable Devices Market Share - by Age Group
    - 13.2.3.3.6 Japan: Asia Pacific Aesthetic Injectable Devices Market Share - by Gender
    - 13.2.3.3.7 Japan: Asia Pacific Aesthetic Injectable Devices Market Share - by End User
  - 13.3.4.4 India: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.3.4.4.1 India: Asia Pacific Aesthetic Injectable Devices Market Share - by Product
    - 13.3.4.4.2 India: Asia Pacific Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 13.3.4.4.3 India: Asia Pacific Aesthetic Injectable Devices Market Share - by Device
    - 13.3.4.4.4 India: Asia Pacific Aesthetic Injectable Devices Market Share - by Application
    - 13.3.4.4.5 India: Asia Pacific Aesthetic Injectable Devices Market Share - by Age Group
    - 13.3.4.4.6 India: Asia Pacific Aesthetic Injectable Devices Market Share - by Gender
    - 13.3.4.4.7 India: Asia Pacific Aesthetic Injectable Devices Market Share - by End User
  - 13.4.5.5 Australia: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.4.5.5.1 Australia: Asia Pacific Aesthetic Injectable Devices Market Share - by Product
    - 13.4.5.5.2 Australia: Asia Pacific Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 13.4.5.5.3 Australia: Asia Pacific Aesthetic Injectable Devices Market Share - by Device
    - 13.4.5.5.4 Australia: Asia Pacific Aesthetic Injectable Devices Market Share - by Application
    - 13.4.5.5.5 Australia: Asia Pacific Aesthetic Injectable Devices Market Share - by Age Group
    - 13.4.5.5.6 Australia: Asia Pacific Aesthetic Injectable Devices Market Share - by Gender
    - 13.4.5.5.7 Australia: Asia Pacific Aesthetic Injectable Devices Market Share - by End User
  - 13.5.6.6 South Korea: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.5.6.6.1 South Korea: Asia Pacific Aesthetic Injectable Devices Market Share - by Product
    - 13.5.6.6.2 South Korea: Asia Pacific Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 13.5.6.6.3 South Korea: Asia Pacific Aesthetic Injectable Devices Market Share - by Device
    - 13.5.6.6.4 South Korea: Asia Pacific Aesthetic Injectable Devices Market Share - by Application
    - 13.5.6.6.5 South Korea: Asia Pacific Aesthetic Injectable Devices Market Share - by Age Group
    - 13.5.6.6.6 South Korea: Asia Pacific Aesthetic Injectable Devices Market Share - by Gender
    - 13.5.6.6.7 South Korea: Asia Pacific Aesthetic Injectable Devices Market Share - by End User
  - 13.6.7.7 Rest of APAC: Asia Pacific Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.6.7.7.1 Rest of APAC: Asia Pacific Aesthetic Injectable Devices Market Share - by Product
    - 13.6.7.7.2 Rest of APAC: Asia Pacific Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 13.6.7.7.3 Rest of APAC: Asia Pacific Aesthetic Injectable Devices Market Share - by Device
    - 13.6.7.7.4 Rest of APAC: Asia Pacific Aesthetic Injectable Devices Market Share - by Application
    - 13.6.7.7.5 Rest of APAC: Asia Pacific Aesthetic Injectable Devices Market Share - by Age Group
    - 13.6.7.7.6 Rest of APAC: Asia Pacific Aesthetic Injectable Devices Market Share - by Gender
    - 13.6.7.7.7 Rest of APAC: Asia Pacific Aesthetic Injectable Devices Market Share - by End User

14 Competitive Landscape

14.1 Heat Map Analysis by Key Players
14.2 Company Positioning & Concentration

15 Industry Landscape

15.1 Overview
15.2 New Product Development
15.3 Merger and Acquisition
15.4 Other Strategic Developments

17 COMPANY PROFILES

16.1 Merz Pharma GmbH & Co KGaA
- 16.1.1 Key Facts
- 16.1.2 Business Description
- 16.1.3 Products and Services
- 16.1.4 Financial Overview
- 16.1.5 SWOT Analysis
- 16.1.6 Key Developments
16.2 AbbVie Inc
- 16.2.1 Key Facts
- 16.2.2 Business Description
- 16.2.3 Products and Services
- 16.2.4 Financial Overview
- 16.2.5 SWOT Analysis
- 16.2.6 Key Developments
16.3 Ipsen SA
- 16.3.1 Key Facts
- 16.3.2 Business Description
- 16.3.3 Products and Services
- 16.3.4 Financial Overview
- 16.3.5 SWOT Analysis
- 16.3.6 Key Developments
16.4 Mesoestetic E-Commerce SL
- 16.4.1 Key Facts
- 16.4.2 Business Description
- 16.4.3 Products and Services
- 16.4.4 Financial Overview
- 16.4.5 SWOT Analysis
- 16.4.6 Key Developments
16.5 Galderma SA
- 16.5.1 Key Facts
- 16.5.2 Business Description
- 16.5.3 Products and Services
- 16.5.4 Financial Overview
- 16.5.5 SWOT Analysis
- 16.5.6 Key Developments
16.6 Revance Therapeutics Inc
- 16.6.1 Key Facts
- 16.6.2 Business Description
- 16.6.3 Products and Services
- 16.6.4 Financial Overview
- 16.6.5 SWOT Analysis
- 16.6.6 Key Developments
16.7 Medytox Inc
- 16.7.1 Key Facts
- 16.7.2 Business Description
- 16.7.3 Products and Services
- 16.7.4 Financial Overview
- 16.7.5 SWOT Analysis
- 16.7.6 Key Developments
16.8 Sinopharm Group Co Ltd
- 16.8.1 Key Facts
- 16.8.2 Business Description
- 16.8.3 Products and Services
- 16.8.4 Financial Overview
- 16.8.5 SWOT Analysis
- 16.8.6 Key Developments
16.9 Evolus Inc
- 16.9.1 Key Facts
- 16.9.2 Business Description
- 16.9.3 Products and Services
- 16.9.4 Financial Overview
- 16.9.5 SWOT Analysis
- 16.9.6 Key Developments
16.10 Hugel Inc
- 16.10.1 Key Facts
- 16.10.2 Business Description
- 16.10.3 Products and Services
- 16.10.4 Financial Overview
- 16.10.5 SWOT Analysis
- 16.10.6 Key Developments
16.11 Sinclair Pharma Ltd
- 16.11.1 Key Facts
- 16.11.2 Business Description
- 16.11.3 Products and Services
- 16.11.4 Financial Overview
- 16.11.5 SWOT Analysis
- 16.11.6 Key Developments
16.12 Laboratoires Vivacy, S.A.S.
- 16.12.1 Key Facts
- 16.12.2 Business Description
- 16.12.3 Products and Services
- 16.12.4 Financial Overview
- 16.12.5 SWOT Analysis
- 16.12.6 Key Developments

17. Appendix

17.1 About The Insight Partners